ebomi
Colour theme
Sign in
Insider · CIK 0001434099

Brandt Peter C.

CIK 0001434099 Name as filed on the most recent filing

Filed as Brandt Peter C. (8)

40 transaction lines · from 8 filings · filed 2008-05-15 to 2022-08-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

40 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-08-16 In8Bio, Inc.
INAB 		P, Open-market purchase 105,263 acquired 1.90 199,999.70 Form 4, filing 0001209191-22-046598
2012-02-28 Auxilium Pharmaceuticals Inc
AUXL 		P, Open-market purchase 9,700 acquired 20.10 194,970.00 Form 4, filing 0001209191-12-014552
2012-02-28 Auxilium Pharmaceuticals Inc
AUXL 		P, Open-market purchase 300 acquired 20.09 6,028.20 Form 4, filing 0001209191-12-014552
2011-09-09 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 55,100 acquired 1.22 67,222.00 Form 4, filing 0001140361-11-045494
2011-09-09 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 13,300 acquired 1.22 16,212.70 Form 4, filing 0001140361-11-045494
2011-09-09 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 6,600 acquired 1.21 7,986.00 Form 4, filing 0001140361-11-045494
2011-09-09 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 5,000 acquired 1.23 6,150.00 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 15,000 acquired 1.08 16,185.00 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 13,800 acquired 1.10 15,180.00 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 7,200 acquired 1.12 8,064.00 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 5,912 acquired 1.09 6,444.08 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 2,500 acquired 1.10 2,747.50 Form 4, filing 0001140361-11-045494
2011-09-08 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 588 acquired 1.13 663.85 Form 4, filing 0001140361-11-045494
2011-09-07 Epocrates Inc
EPOC 		P, Open-market purchase 14,568 acquired 9.78 142,431.34 Form 4, filing 0001096738-11-000018
2011-09-07 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 5,000 acquired 1.04 5,200.00 Form 4, filing 0001140361-11-045204
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 4,468 acquired 9.58 42,803.44 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 2,400 acquired 9.59 23,013.60 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 2,200 acquired 9.59 21,098.00 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 500 acquired 9.58 4,789.50 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 400 acquired 9.59 3,835.60 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 232 acquired 9.55 2,215.60 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 200 acquired 9.55 1,910.00 Form 4, filing 0001096738-11-000017
2011-09-06 Epocrates Inc
EPOC 		P, Open-market purchase 32 acquired 9.57 306.24 Form 4, filing 0001096738-11-000017
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 5,300 acquired 0.95 5,019.10 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 4,500 acquired 0.94 4,252.50 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 3,900 acquired 0.94 3,685.50 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 3,250 acquired 0.95 3,081.00 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 2,450 acquired 0.95 2,317.70 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 300 acquired 0.94 283.50 Form 4, filing 0001140361-11-045204
2011-09-06 Rexahn Pharmaceuticals, Inc.
RNN 		P, Open-market purchase 300 acquired 0.94 283.20 Form 4, filing 0001140361-11-045204
2008-08-29 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 19,059 acquired 12.39 236,141.01 Form 4, filing 0001209191-08-049927
2008-08-29 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 527 acquired 12.38 6,524.26 Form 4, filing 0001209191-08-049927
2008-08-29 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 299 acquired 12.36 3,695.64 Form 4, filing 0001209191-08-049927
2008-08-29 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 115 acquired 12.37 1,422.55 Form 4, filing 0001209191-08-049927
2008-05-14 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 10,000 acquired 9.82 98,200.00 Form 4, filing 0001209191-08-030424
2008-05-14 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 10,000 acquired 9.76 97,600.00 Form 4, filing 0001209191-08-030424
2008-05-13 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 2,884 acquired 9.86 28,436.24 Form 4, filing 0001209191-08-030424
2008-05-13 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 1,000 acquired 9.73 9,730.00 Form 4, filing 0001209191-08-030424
2008-05-13 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 916 acquired 9.79 8,967.64 Form 4, filing 0001209191-08-030424
2008-05-13 Noven Pharmaceuticals Inc
NOVN 		P, Open-market purchase 200 acquired 9.69 1,938.00 Form 4, filing 0001209191-08-030424

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 40
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Brandt Peter C., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001434099

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.